Françoise Brizard - Concepedia

Author

Françoise Brizard

Centre Hospitalier Universitaire de Poitiers

Also Known As

F Brizard, F. Brizard, Francoise Brizard, Françoise Brizard, FranÇOise Brizard, Françoise Brizard

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Poitiers Inserm Centre National de la Recherche Scientifique Université de Poitiers Laboratoire de Génétique Cellulaire

About

Françoise Brizard is an author at Centre Hospitalier Universitaire de Poitiers specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	556
2	Cell Biology	6	6	361
3	Immunology	6	6	128
4	Health Sciences	4	4	244
5	Molecular Biology	1	1	49

Françoise Brizard

Publications

917

Citations

H-Index

Page 1

	Year	Citations
Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia HA Drabkin, C Parsy, Kevin L. Ferguson, Leukemia Hematological MalignancyChromatinMedicineMixed-phenotype Acute LeukemiaHematology	2002	187
Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-α therapy or allogeneic bone marrow transplantation Jean‐Claude Chomel, Françoise Brizard, Anne Veinstein, Blood	2000	93
A complex pattern of recurrent chromosomal losses and gains in T‐cell prolymphocytic leukemia Jean Soulier, Gaëlle Pierron, Danielle Vecchione, Genes Chromosomes and Cancer	2001	88
Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors Chantal Desmaze, Françoise Brizard, Claude Turc‐Carel, Cancer Genetics and Cytogenetics Tumor BiologyTumor HeterogeneityMedicineGeneticsPathology	1997	70
Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages Élise Chapiro, Nathalie Leporrier, Isabelle Radford‐Weiss, Leukemia Research Hematological MalignancyChromatinShort ArmChromosome AberrationMixed-phenotype Acute Leukemia	2009	65
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia Éric Pasmant, Brigitte Gilbert‐Dussardier, Arnaud Petit, Oncogene Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyHematology	2014	53
Fluorescence in situ hybridization analysis of chromosome 1 abnormalities in hematopoietic disorders: rearrangements of DNA satellite II and new recurrent translocations Maryvonne Busson‐Le Coniat, Nicole Dastugue, Odile Maarek, Leukemia ChromatinGenome InstabilityChromosome DynamicsCytogeneticsGenetic Disorder	1999	49
Human <i>LPP</i> gene is fused to <i>MLL</i> in a secondary acute leukemia with a t(3;11) (q28;q23) Laurence Dahéron, Anne Veinstein, Françoise Brizard, Genes Chromosomes and Cancer	2001	47
Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias. Françoise Brizard, A. Brizard, François Guilhot, PubMed	1994	33
Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the <scp>I</scp>nternational <scp>R</scp>egistry for <scp>C</scp>hronic <scp>M</scp>yeloid <scp>L</scp>eukemia in <scp>C</scp>hildren and <scp>A</scp>dolescents Frédéric Millot, Christelle Dupraz, Joëlle Guilhot, Cancer	2017	31

Page 1